Stocktoria

Electromedical Technologies, Inc EMED

OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2019-06-17

Electromedical Technologies, Inc (EMED) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2023 revenue was $1.3M at a -195.8% net margin.

4/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$0.00 as of 2026-06-01 · +0% 1y
$0.00$0.0052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Beneish M-score: -10.81 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Net margin-195.8%
Revenue trend · last 5y · up

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 45%
Net marginstronger than 19%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
EMEDElectromedical Technologies, Inc4/9
ICUSeaStar Medical Holding Corp3/9
PETVPetVivo Holdings, Inc.3/9
EBRCZEBR Systems, Inc.2/9-12.31
SINTSintx Technologies, Inc.2/9
CODXCo-Diagnostics, Inc.1/9-16.26
FEMYFEMASYS INC2/9

All Manufacturing companies →

FAQ

Is EMED financially healthy?

Electromedical Technologies, Inc's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).

Does EMED pay a dividend?

No, Electromedical Technologies, Inc does not currently pay a dividend.

How profitable is EMED?

In FY2023, Electromedical Technologies, Inc had a net margin of -195.8%.

Source: SEC EDGAR filings · CIK 0001715819 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.